🔴 Nasus Pharma is trading 5.1% down today amid broader Nasdaq weakness

Nasus Pharma is trading at $2.96 (-5.12%) as broader market pressure and Nasdaq weakness weigh on smaller growth names.

• No company-specific catalysts, such as earnings, FDA updates, or major deals, were identified to explain the move.
• The decline appears to be sentiment-driven, reflecting mixed performance across U.S. markets.